Drug intelligence / Profile preview

Qingjin Tongluo Formula

Development stage: Unknown
Lead developer: Key Disease Projects of the National Inheritance and Innovation Center

Overview

Qingjin Tongluo Formula is a Traditional Chinese Medicine formula currently undergoing clinical investigation for the treatment of Mycoplasma pneumoniae pneumonia in children. Its therapeutic principles are rooted in the Traditional Chinese Medicine concept of addressing the "Syndrome of Heat Pathogen Blocking the Lung."

Other names: 清金通络方

Beyond the preview

Go deeper on Qingjin Tongluo Formula.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qingjin Tongluo Formula.